Salix Pharmaceuticals to Present at Banc of America Health Care Confer

    Business Editors/Health Editors
    BIOWIRE2K
    Banc of America Securities Healthcare Conference 2005

    RALEIGH, N.C.--(BUSINESS WIRE)--May 12, 2005--Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that the Company will present at Banc of America Securities Heath Care Conference in Las Vegas, NV on Thursday, May 19 at 11:40 a.m. ET.
    Interested parties can access a live audio web cast of the presentation at http://www.salix.com. A replay of the presentation will be available at the same location.
    Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's 100-member gastroenterology specialty sales and marketing team. Salix markets COLAZAL(R), XIFAXAN(TM), AZASAN(R), ANUSOL-HC(R) and PROCTOCORT(R). A granulated mesalamine product also is under development. Salix trades on the Nasdaq National Market under the ticker symbol "SLXP".
    For more information please contact the Company at 919-862-1000 or visit our web site at www.salix.com. Information on our web site is not incorporated in our SEC filings.

--30--MD/ch*

CONTACT: Salix Pharmaceuticals, Ltd. Adam C. Derbyshire or Mike Freeman, 919-862-1000

KEYWORD: NEVADA NORTH CAROLINA TRACK INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: Salix Pharmaceuticals, Ltd.

Copyright Business Wire 2005